Quantcast
Study Finds Many Patients Excluded From Clinical Trials Due

Study Finds Many Patients Excluded From Clinical Trials Due To Prior Cancer

UT Southwestern Medical Center Lung cancer clinical trials exclude a substantial proportion of patients due to a history of prior cancer, as shown in an analysis by cancer researchers at UT Southwestern Medical Center. Among more than 50...

Latest pharmaceutical industry Stories

2014-09-30 12:30:55

DENVER, Sept. 30, 2014 /PRNewswire/ -- According to their CEO, Rob Bohacs - "the world of cancer clinical trials is going through a complete transformation with highly targeted biomarker clinical trials and the work of the current clinical trial management process isn't configured to accommodate these types of 'next generation' clinical trials, which will ultimately drive the prescription cancer drugs of tomorrow." The company has been recognized by the National Cancer Institute as...

2014-09-30 08:32:38

Acquisition Strengthens Existing Pipeline in Viral Diseases NEW BRUNSWICK, N.J., Sept. 30, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash. The acquisition will include Alios BioPharma's portfolio of potential therapeutics for viral infections including...

2014-09-30 08:32:14

DUBLIN, Sept. 30, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it intends to release third quarter 2014 financial results on Wednesday, November 5, 2014, prior to the open of the U.S. financial markets. The Company will host a conference call and webcast at 8:00 a.m. Eastern Standard Time on Wednesday, November 5, 2014 to discuss its financial results. The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the...

2014-09-30 08:30:41

MUMBAI, September 30, 2014 /PRNewswire/ -- China's regulatory framework for in-vitro diagnostic reagents is undergoing earthshaking changes. The country's new leaders have recognized that the regulations for supervision and administration of in-vitro diagnostic reagents are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest "Regulations for the Supervision and Administration of Medical...

2014-09-29 23:13:20

Clinovo Will Demo Its Advanced Electronic Data Capture Solution, ClinCapture at The Annual “Society for Clinical Data Management” (SCDM) Conference Sunnyvale, CA (PRWEB) September 29, 2014 Clinovo, global Contract Research Organization (CRO) with headquarters in the San Francisco Bay Area, exhibits the annual “Society for Clinical Data Management” (SCDM) Conference on September 28th – October 1st in Las Vegas (NV). At this conference, Clinovo team will provide demonstration of...

2014-09-29 23:10:17

The latest report in Atlantic Information Services’s Management Insight Series draws on case studies to provide multi-pronged strategies to manage specialty drug coupons without compromising patient access. Washington, DC (PRWEB) September 29, 2014 Atlantic Information Services, Inc. (AIS) is pleased to announce the release of Copay Coupons for Specialty Drugs: Strategies for Health Plans and PBMs, the latest report in its Management Insight Series. The report provides details of steps...

2014-09-29 16:25:32

TORONTO, Sept. 29, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") (OTC: PTGEF, Canadian Securities Exchange: PBT.U), is pleased to announce that its three Promissory Note holders, two of whom are the directors of Portage, who advanced $ 100,000 each in July 2014 for a total of $ 300,000 opted to have their Notes and related Coupons converted into 3,500,001 restricted common shares. Notes were repayable within one year and carried 5% coupon. Both the Note and the...

2014-09-29 12:30:15

INDIANAPOLIS, Sept. 29, 2014 /PRNewswire/ -- On Oct. 2, some 24,000 Lilly employees spanning nearly 60 countries will participate in the company's seventh Global Day of Service. Building on Lilly's strong heritage of making life better, employees will join together in a single, coordinated effort to improve the communities where they work, live and play. "I'm so proud of this tradition, and of our Lilly people who devote their talent and energy to strengthening the communities around the...

2014-09-29 12:30:04

PRINCETON N.J., Sept. 29, 2014 /PRNewswire/ -- Guerbet, a pioneer in the field of contrast agents for medical imaging, has received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration for its assistance in preventing or alleviating a drug shortage. Guerbet is being recognized for its efforts related to the shortage of Ethiodol (ethiodized oil) injection, including acquiring the new drug application, submitting several post-approval supplements to restart...

2014-09-29 12:28:47

CHENGDU, China, Sept. 29, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that its Qionglai Facility (QLF) has successfully completed the official site visit by the China Food & Drug Administration's (CFDA) for its Good Manufacturing Practice (GMP)...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'